Wednesday, August 16, 2017

FDA Recalls Liquid Pharmaceutical Products

WebMD-7 hours ago
"B. cepacia poses a serious threat to vulnerable patients, including infants and young children who still have developing immune systems," FDA Commissioner ...
Post a Comment